Partner Headlines - BCRX

  1. Unusual Options Activity: TSO, AMD, DAL & More

    TalkMarkets
  2. Biotechs Fade Again In Late Day Sell-Off

    TalkMarkets
  3. Benzinga's Top Downgrades

    Benzinga
  4. Mid-Afternoon Market Update: Crude Oil Down 3%; Biocryst Pharmaceuticals ...

    Benzinga
  5. Mid-Day Market Update: Dow Tumbles Over 350 Points; Apollo Education ...

    Benzinga
  6. Mid-Morning Market Update: Markets Open Lower; Hasbro Beats Q4 ...

    Benzinga
  7. BioCryst Pharmaceuticals Is Plummeting 65%

    Benzinga
  8. Biocryst Pharmaceuticals Says Oral Administration Of Avoralstat ...

    Benzinga
  9. 10 Stocks Moving In Tuesday's Pre-Market Session

    Benzinga
  10. Benzinga's Top Downgrades

    Benzinga
  11. Morning Market Losers

    Benzinga
  12. US Stock Futures Down Ahead Of Fed Minutes

    Benzinga
  13. BioCryst Announces Successful Phase 1 Clinical Trial of BCX7353

    Benzinga
  14. Robert Ingram Named to BioCryst's Board of Directors

    Benzinga
  15. 6 Movers To Keep An Eye On Next Week

    Benzinga
  16. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX443 ...

    Benzinga
  17. Benzinga's Top Upgrades

    Benzinga
  18. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga
  19. Tekmira falls on Ebola news

    IBD
  20. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD
  21. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga
  22. US Stock Futures Rise Ahead Of Economic Data

    Benzinga
  23. BioCryst Announces Initiation of a Phase 1 Clinical Trial of ...

    Benzinga
  24. Benzinga's Top Initiations

    Benzinga
  25. Benzinga's Top Upgrades

    Benzinga
  26. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected ...

    Benzinga
  27. Benzinga's Top #PreMarket Gainers

    Benzinga
  28. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  29. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  30. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  31. BioCryst Pharmaceuticals'

    IBD
  32. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga
  33. Benzinga's Top #PreMarket Gainers

    Benzinga
  34. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  35. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  36. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals ...

    Benzinga
  37. Ebola Vaccine Contenders

    Benzinga
  38. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  39. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  40. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  41. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  42. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  43. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  44. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  45. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  46. Benzinga's Top #PreMarket Gainers

    Benzinga
  47. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  48. Making Money With Charles Payne: 10/0614

    FoxBusiness
  49. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  50. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  51. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  52. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  53. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  54. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  55. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  56. Morning Market Movers

    Benzinga
  57. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  58. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  59. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  60. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  61. Momentum Stocks Showing Weakness

    Benzinga
  62. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  63. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  64. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  65. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  66. Biotechs That Might Benefit From Ebola

    Benzinga
  67. Benzinga's Top #PreMarket Gainers

    Benzinga
  68. Stocks Hitting 52-Week Highs

    Benzinga
  69. Benzinga's Top Initiations

    Benzinga
  70. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  71. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  72. Ebola Stocks Continue Higher

    Benzinga
  73. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  74. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  75. Benzinga's Top Initiations

    Benzinga
  76. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  77. Benzinga's Top #PreMarket Gainers

    Benzinga
  78. Benzinga's Top Downgrades

    Benzinga
  79. Benzinga's Top Initiations

    Benzinga
  80. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  81. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  82. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  83. Benzinga's Top #PreMarket Gainers

    Benzinga
  84. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  85. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  86. Benzinga's Top Pre-Market Gainers

    Benzinga
  87. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  88. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  89. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  90. Benzinga's Top Pre-Market Gainers

    Benzinga
  91. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  92. Benzinga's Top Pre-Market Gainers

    Benzinga
  93. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  94. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  95. Benzinga's Top Pre-Market Losers

    Benzinga
  96. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  97. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  98. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  99. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  100. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
Trading Center